糖尿病肾病中的系膜细胞:从发病机制到治疗意义

Mesangial Cells in Diabetic Kidney Disease: From Mechanisms to Therapeutic Implications.

作者信息

Feng Li, Feng Yu-Ying, Ren Qian, Fu Ping, Ma Liang

机构信息

Department of Nephrology, Institute of Kidney Diseases, West China Hospital of Sichuan University, and National Key Laboratory of Kidney Diseases, Chengdu 610041, China.

出版信息

Int J Biol Sci. 2025 Jul 24;21(11):4762-4781. doi: 10.7150/ijbs.114907. eCollection 2025.

Abstract

Diabetic kidney disease (DKD) is a serious diabetic complication, the morbidity and mortality of which has rapidly increased worldwide. As known, the pathogenesis of DKD is complex and includes mesangial cell (MC) proliferation and hypertrophy, mesangial expansion, glomerular basement membrane thickening, podocyte detachment, and tubulointerstitial damage. Thus, the role of MCs cannot be underestimated, as their exclusive positioning and diverse physiological functions are crucial for preserving the glomerular filtration membrane's composition and functionality. Considerable animal studies and clinical trials have elaborated that MCs are pivotal to the occurrence and progression of DKD. In this review, we summarize and outline the mechanisms of MC injury and the interactions of MCs with other cells and discuss the progress of MC-targeted therapeutics to provide a comprehensive perspective on the prevention and treatment of DKD.

摘要

糖尿病肾病(DKD)是一种严重的糖尿病并发症,其发病率和死亡率在全球范围内迅速上升。众所周知,DKD的发病机制复杂,包括系膜细胞(MC)增殖和肥大、系膜扩张、肾小球基底膜增厚、足细胞脱落以及肾小管间质损伤。因此,MC的作用不可低估,因为它们独特的定位和多样的生理功能对于维持肾小球滤过膜的组成和功能至关重要。大量的动物研究和临床试验已阐明,MC对DKD的发生和发展起着关键作用。在本综述中,我们总结并概述了MC损伤的机制以及MC与其他细胞的相互作用,并讨论了针对MC的治疗进展,以期为DKD的预防和治疗提供全面的视角。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索